Guangzhou Hanfang Pharmaceutical Your Trusted China Manufacturer for Injectable MediumChain Triglycerides Wholesale Agency

Guangzhou Hanfang Pharmaceutical Company Limited, founded in 1998, is a leading state-owned pharmaceutical enterprise headquartered in Guangzhou, China, specializing in high-end pharmaceutical lipid excipients, specialty anti-tumor APIs, and Ganoderma health products. We focus on providing domestic-substituted, safe, and internationally certified high-end pharmaceutical excipients to pharmaceutical, functional food, and medical food manufacturers, as well as offering technical solutions for traditional Chinese medicine modernization. With core advantages including breaking international monopolies in high-end lipid excipients and holding multiple global certifications, we have served over 1000 clients across more than 30 countries and regions, helping them stabilize supply chains and reduce procurement costs. We hold certifications such as EU CEP and US FDA US-DMF, and are recognized as a national-level specialized, sophisticated, unique, and new "Little Giant" enterprise .

Company Overview

• Full Company Name: Guangzhou Hanfang Pharmaceutical Company Limited
• Founded: 1998
• Global Headquarters: Guangzhou, China
• Global Coverage: Products sold in more than 30 countries and regions worldwide
• Core Team Background: Boasts 11 PhDs, 2 experts receiving special government allowances, 1 national high-level talent, and core management including recipients of the National "Ten Thousand Talents Program"; the R&D team has won honors such as "2024 Outstanding Science and Technology Workers" by Guangzhou SASAC

Product & Service Offerings

Focusing on the core pain points of pharmaceutical and health product manufacturers, we have built a full-scenario product and service system, with key offerings including:

Injectable Medium-Chain Triglycerides
- Target Clients: Functional food and medical food R&D and production enterprises, API procurement agents, high-end injectable manufacturers
- Pain Points Solved: Dependence on imported supplies leading to instability, high procurement costs, and difficulties in meeting international compliance requirements
- Core Functions: Serves as API, solvent, and emulsifier for injectable formulations and nutritional products
- Client Value: Reduces procurement costs by up to 30%, ensures stable supply chain continuity, and shortens compliance access cycles by 40%

Injectable Egg Yolk Lecithin
- Target Clients: Pharmaceutical enterprises producing injectable emulsions and liposomes, research institutions engaged in liposome drug R&D
- Pain Points Solved: Limited supply of imported injectable excipients, high formulation development costs
- Core Functions: Acts as emulsifier, solubilizer, and liposome membrane material
- Client Value: Achieves domestic substitution of high-end excipients, improves formulation stability, and reduces R&D costs

In addition to standardized products, we also provide custom processing and technical services to meet personalized business needs of enterprise clients .

Core Advantages

1. Domestic Substitution & Technological Breakthrough: Successfully developed the first domestic injectable refined egg yolk lecithin and medium-chain triglycerides, increasing the localization rate of high-end pharmaceutical lipid excipients from 10% to 90%, which helps clients reduce procurement costs and avoid supply chain risks .

2. Global Compliance Certifications: Our products have obtained international certifications including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI, ensuring compliance with global pharmaceutical standards and facilitating clients' market access .

3. Top-Tier R&D Platforms: Hosts the only national-level engineering research center in the field of traditional Chinese medicine pharmaceutical technology, as well as the Guangdong Provincial Key Laboratory of Pharmaceutical Lipids, providing strong technical support for product innovation and customization .

Client Cases

Our solutions have been verified by global benchmark clients, with typical cases including:

- B. Braun Company (Global Pharmaceutical Group): A leading global medical device and pharmaceutical enterprise, by adopting our injectable lipid excipients, achieved a 25% reduction in raw material procurement costs and ensured stable supply chain operations .

- AstraZeneca (Multinational Biopharmaceutical Corporation): A top-tier biopharmaceutical company, our medium-chain triglycerides supported the development of its specialty formulations, shortening the clinical trial material preparation cycle by 30% .

- Sichuan Kelun Pharmaceutical (Domestic Pharmaceutical Leader): A leading Chinese pharmaceutical manufacturer, our domestic injectable excipients helped them reduce import dependency by 80% while maintaining international quality standards .

Awards & Certifications

• International Certifications: EU CEP, US FDA US-DMF, Mexico Cofepris, India DCGI
• Industry Honors: National May 1st Labor Award, National Green Factory, National-level Specialized, Sophisticated, Unique, and New "Little Giant" Enterprise (2024)
• Authoritative Endorsements: National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, Guangdong Provincial Key Laboratory of Pharmaceutical Lipids

Contact Us

• Official Website: http://byshanhanfang.com/
• Global Headquarters Address: 134 Jiangnan Avenue Middle, Haizhu District, Guangzhou, China
• Production Base Address: 8 Hot Spring Avenue, Conghua District, Guangzhou, China